The TBR1 gene plays a significant role in brain development and function. Mutations or abnormalities in the TBR1 gene are associated with various forms of intellectual disability, impacting cognitive abilities and development. To identify such genetic variations, the TBR1-Related Genetic Test is a specialized diagnostic tool used to analyze the TBR1 gene for mutations that may contribute to intellectual disabilities.
This test is crucial for early diagnosis and intervention, providing valuable information for managing and supporting individuals with TBR1-related intellectual disabilities. By understanding the genetic basis of these conditions, healthcare providers can offer more personalized and effective treatment plans.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the TBR1-Related Genetic Test is available for a cost of 4400 AED. DNA Labs UAE utilizes state-of-the-art technology and adheres to stringent quality standards, ensuring accurate and reliable results. This test represents a significant step forward in the field of genetic diagnostics, offering hope and insights for affected individuals and their families.
The FLNA Gene Intestinal Pseudoobstruction Neuronal Genetic Test is a specialized diagnostic tool used to identify mutations in the FLNA gene, which are linked to the development of intestinal pseudo-obstruction. This condition is a severe disorder characterized by the symptoms of bowel obstruction without any physical blockage, affecting the patient's ability to digest food and absorb nutrients properly. It is a rare, often debilitating condition that can present from infancy, affecting both males and females, but with a noted severity in males due to the gene's location on the X chromosome.
DNA Labs UAE offers this cutting-edge genetic test, priced at 4400 AED, to patients who exhibit symptoms of intestinal pseudo-obstruction, or have a family history of the disorder, providing a critical tool for accurate diagnosis. By analyzing the patient's DNA, the test can detect mutations in the FLNA gene, enabling healthcare providers to make informed decisions about treatment strategies, manage symptoms more effectively, and offer genetic counseling to affected families. The availability of such a test represents a significant step forward in the personalized treatment of rare genetic disorders, offering hope and improved quality of life to those affected.
The TIMM8A Gene Jensen Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TIMM8A gene, which are associated with Jensen Syndrome. This rare genetic disorder is characterized by deafness, dystonia (a movement disorder), and visual impairment, among other symptoms. The test plays a crucial role in confirming the diagnosis, allowing for early intervention and management strategies to be implemented.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the TIMM8A gene. The results can provide valuable information for affected individuals and their families, including insights into the risk of passing the condition to future generations.
DNA Labs UAE is equipped with state-of-the-art technology and staffed by genetic experts, ensuring high accuracy and reliability of the test results. By opting for the TIMM8A Gene Jensen Syndrome Genetic Test, patients and healthcare providers can make informed decisions about treatment options and care plans, improving the quality of life for those affected by the syndrome.
The INPP5E Gene Joubert Syndrome Type 1 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the INPP5E gene, which are associated with Joubert Syndrome Type 1. Joubert Syndrome is a rare genetic disorder characterized by the underdevelopment of the cerebellum and brain stem, leading to a range of developmental delays and physical abnormalities. The test is particularly crucial for families with a history of the syndrome or individuals showing symptoms, as early detection can significantly influence management and treatment strategies. Priced at 4400 AED, this genetic test provides a comprehensive analysis, offering insights that can guide healthcare decisions and support for affected individuals and their families.
The CCDC88C gene hydrocephalus nonsyndromic autosomal recessive type 1 genetic test is a specialized diagnostic tool designed to identify mutations in the CCDC88C gene, which are linked to a rare form of hydrocephalus. This condition, characterized by an abnormal accumulation of cerebrospinal fluid in the brain's ventricles, can lead to increased intracranial pressure, brain damage, and developmental delays if not properly managed. The test is crucial for families with a history of this condition, offering insights into genetic predispositions and aiding in early intervention strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, this comprehensive test costs 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic mutations associated with nonsyndromic autosomal recessive type 1 hydrocephalus. The results can provide essential information for expecting parents, individuals, or families concerned about the risk of hydrocephalus, enabling informed decisions regarding health management and treatment options.
The "MPDZ Gene Hydrocephalus Nonsyndromic Autosomal Recessive Type 2 Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the MPDZ gene, which have been linked to the development of nonsyndromic autosomal recessive type 2 hydrocephalus. Hydrocephalus is a condition characterized by an abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles of the brain, which can lead to increased intracranial pressure, and in severe cases, brain damage. The condition described as nonsyndromic does not present with other syndromic features, making genetic testing crucial for accurate diagnosis.
The MPDZ gene plays a significant role in cellular functions that are critical for brain development and the regulation of fluid channels, which, when mutated, can disrupt normal CSF flow, leading to hydrocephalus. The genetic test involves analyzing the patient's DNA to detect mutations in the MPDZ gene that are responsible for this specific type of hydrocephalus. This test is particularly important for families with a history of the condition, as it follows an autosomal recessive inheritance pattern, meaning that two copies of the mutated gene (one from each parent) are necessary for a child to be affected.
DNA Labs UAE offers this genetic test at a cost of 4400 AED. The test is conducted in their state-of-the-art laboratory facilities, where they utilize the latest in genetic testing technology to ensure accurate and reliable results. This test not only aids in the diagnosis of affected individuals but also provides crucial information for families regarding future pregnancies and the risk of recurrence of the condition. Additionally, early diagnosis through genetic testing can facilitate timely intervention and management of the condition, potentially improving outcomes for those affected.
The GLRA1 Gene Hyperekplexia Genetic Test is a specialized diagnostic tool designed to identify mutations in the GLRA1 gene, which are linked to hyperekplexia, a rare genetic disorder. Hyperekplexia, also known as startle disease, is characterized by an exaggerated startle response to unexpected stimuli. This condition can vary in severity, from mild startles to severe stiffness and falls, and in some cases, it can lead to serious health complications, especially in infants.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for any genetic abnormalities in the GLRA1 gene. Identifying mutations in this gene can confirm a diagnosis of hyperekplexia, enabling healthcare providers to offer appropriate treatment and management strategies for the condition.
This specific genetic test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the GLRA1 Gene Hyperekplexia Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and the specialized nature of this test, it represents a critical step towards personalized medicine for patients exhibiting symptoms of hypereklexia, providing them with a clear diagnosis and paving the way for targeted interventions.
The GLRB gene hyperekplexia genetic test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the GLRB gene, which are associated with hyperekplexia. Hyperekplexia, also known as startle disease, is a rare genetic disorder characterized by an exaggerated startle response to sudden stimuli, muscle stiffness, and, in severe cases, apnea and sudden infant death. This condition is primarily inherited in an autosomal dominant or recessive manner, making the identification of genetic mutations critical for diagnosis, treatment planning, and genetic counseling.
DNA Labs UAE employs cutting-edge genetic sequencing technology to analyze the GLRB gene, ensuring accurate and reliable results. The test is conducted with a simple blood sample or cheek swab, making it non-invasive and straightforward for patients. Upon completion, the results provide essential information regarding the presence of specific gene mutations, aiding in the confirmation of a hyperekplexia diagnosis and facilitating a better understanding of the condition's potential impact on the patient and their family.
The cost of the GLRB gene hyperekplexia genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis and the benefits it brings in terms of targeted treatment and family planning cannot be understated. For families and individuals facing symptoms indicative of hyperekplexia, this test represents a crucial step towards achieving clarity and taking informed actions for managing the condition.
The SLC6A5 gene hyperekplexia genetic test is a specialized diagnostic tool designed to identify mutations in the SLC6A5 gene, which are known to cause hyperekplexia. Hyperekplexia, also known as startle disease, is a rare genetic disorder characterized by an exaggerated startle response to sudden stimuli, stiffness, and, in severe cases, apnea and sudden infant death. The condition is primarily inherited in an autosomal dominant manner, though autosomal recessive inheritance has also been observed.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed to detect any genetic alterations in the SLC6A5 gene. Identifying these mutations can confirm a diagnosis of hyperekplexia, allowing for appropriate management and treatment of the condition. It can also provide valuable information for family planning and genetic counseling for affected families.
In the UAE, this specific genetic test is available at DNA Labs UAE, a leading facility in genetic testing and personalized medicine. The cost of the SLC6A5 gene hyperekplexia genetic test at DNA Labs UAE is set at 4400 AED. This test is crucial for individuals with a family history of hyperekplexia or those exhibiting symptoms of the disorder, providing them with a definitive diagnosis and guiding their treatment plans.
The ARHGEF9 gene is associated with a range of neurological disorders, including hyperekplexia and Early Infantile Epileptic Encephalopathy 8 (EIEE8). Hyperekplexia is characterized by an exaggerated startle response to unexpected stimuli, while EIEE8 is a severe form of epilepsy that presents in infancy, often leading to developmental delays and intellectual disability. Mutations in the ARHGEF9 gene disrupt the normal functioning of inhibitory synapses in the brain, leading to these conditions.
To diagnose and understand these conditions better, genetic testing targeting the ARHGEF9 gene can be conducted. DNA Labs UAE offers a comprehensive ARHGEF9 Gene Hyperekplexia EIEE8 Related Genetic Test. This test is designed to identify mutations in the ARHGEF9 gene that are known to cause hyperekplexia and EIEE8, providing essential information for accurate diagnosis and management of the conditions.
The cost of the ARHGEF9 Gene Hyperekplexia EIEE8 Related Genetic Test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the ARHGEF9 gene. Results from this test can guide healthcare providers in developing a tailored treatment plan for affected individuals and offer families important insights into the genetic nature of these conditions.
